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Adenoviruses bind to a variety of human cells to cause infection. Both the B2 adenovirus 11 and B1 adenovirus 21 use protein
knobs to bind to complement regulator CD46(SCR1-2) in order to gain entry into host cells. In each complex, the two proteins
are highly negatively charged but bind to each other at an interface with oppositely charged surface patches. We computationally
generated single-alanine mutants of charged residues in the complexes CD46(SCR1-2)-Ad11k and CD46(SCR1-2)-Ad21k. We used
electrostatic clustering and Poisson-Boltzmann free energy calculations to propose a hypothesis on the role of electrostatics in
association. Our results delineate specific interfacial electrostatic interactions that are critical for association in both CD46(SCR1-
2)-Ad11k and CD46(SCR1-2)-Ad21k. These results will serve as a predictive tool in the selection of mutants with desired binding
affinity in experimentalmutagenesis studies.This studywill also serve as a foundation for the design of inhibitors to treat adenovirus
infections.
1. Introduction
Adenoviruses are viral pathogens that target a variety of
organs in the human body [1, 2]. They are highly contagious
and can be deadly against patients with a compromised
immune system [1, 3–7]. There are over 50 serotypes of
adenovirus (Ad), divided among 7 species (A–G) [1, 3–5, 7–
15]. Species B viruses are distinguishable from their ability to
severely infect the respiratory tract, urinary tract, and kidney.
Some subspecies like the B2 adenovirus 11 are primarily
responsible for urinary tract infections, while others like
the B1 adenovirus 21 are more associated with ocular and
respiratory diseases [5, 7–9, 11, 16]. Since no specialized treat-
ments against these B adenoviruses are currently available, it
is of particular interest to study how they interact with the
immune system at the molecular level.
Species B adenoviruses have broad infectivity tropism
by using the ubiquitous CD46 receptor to infiltrate cells
[2, 4, 9, 13, 14]. CD46 is a membrane cofactor protein
(also known as MCP) that is found as a glycoprotein on
all human nucleated cells, including those in the immune
system like monocytes and lymphocytes [3, 8, 15, 17–19].
CD46 is a regulator of complement activation (RCA) and
belongs to a family of proteins whose structures consist of
short consensus repeat (SCR) modules. CD46 works as a
cofactor with factor I, a serine protease that cleaves and
inactivates complement proteins C3b and C4b. By binding to
C3b and C4b, CD46 promotes their degradation [6, 9–12, 14–
16, 18]. That is, it works as a suppressing agent of the immune
system by preventing attack on autologous cells. Studies have
shown that binding of adenovirus, like Ad11, can lead to
CD46 downregulation, which sensitizes cells to complement-
mediated lysis by MAC [14, 19]. After species B adenoviruses
attach to CD46 on a cell, viral invasion of the cell occurs with
endocytosis and macropinocytosis, supported by integrins
[2, 6].
Due to the ubiquitous nature of CD46, type B aden-
oviruses have become useful as gene delivery vectors for
being able to transduce hematopoietic stem cells, dendritic
cells, and malignant tumor cells [2, 3, 7, 8]. Compared with
other species, type B adenoviruses are less susceptible to
inactivation by host immune molecules due to lower levels
of neutralizing antibodies in human sera against the virus
[13]. Many recombinant type B or fiber-swapped adenovirus
vectors have beendeveloped for gene transfer and vaccination
approaches [16]. Thus, the comparison of receptor binding
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Figure 1: CD46(SCR1-2) and adenovirus protein configuration. (a) Geometric configuration for Ad11k or Ad21k in complex with CD46.
Ad11k or Ad21k has three protomers that can bind up to three CD46 molecules, adopting a trimer of dimers conformation. The interactions
are homologous for each CD46molecule. (b) Adenovirus protein binding occurs at the SCR1-SCR2 domains of CD46. Both Ad11k and Ad21k
use two protomers, P1 and P2, to bind CD46 at the SCR1 and SCR2 domains. (c) Structure of CD46(SCR1-2)-Ad11k (PDB ID 3O8E). P1 (blue)
refers to chain A and P2 (green) refers to chain E of the PDB file. (d) Structure of CD46(SCR1-2)-Ad21k (PDB ID 3L89). P1 (blue) refers to
chain B and P2 (green) refers to chain C of the PDB file. In both complexes, P1 buries a greater surface area into CD46(SCR1-2). Molecular
graphics were generated using Chimera [28].
mechanisms toCD46 for different adenoviruseswill be useful
for improving selection of gene delivery vectors [5, 13].
Each of the many capsid vertices on adenoviruses 11
and 21 has a trimeric fiber protein consisting of an N-
terminus, an elongated shaft, and a globular knob domain
that binds with CD46 [1, 2, 6, 7, 11, 19]; the knob domains
of Ad11 and Ad21 are called Ad11k and Ad21k, respectively,
hereafter. Crystal structures show that the viral knob domain
is a trimeric ligand with three identical protomers, and
each protomer binds to a specific part of a CD46 molecule
(Figure 1(a)). CD46 is made of four SCR domains, with the
4th SCR domain (SCR4) linked by an STP (rich in serine,
threonine, and proline) segment, a transmembrane region,
and a cytoplasmic tail [1, 5, 6, 8–10, 12, 16–18]. SCR domains
are connected to each other by a flexible interdomain linker,
and the cytoplasmic tail is attached to the cell surface. Binding
of an adenovirus protomer only occurs at the SCR1 and
SCR2 domains of CD46(SCR1-2), as shown schematically in
Figure 1(b) [2, 5, 7, 8, 17–19].
Crystallization studies show that three protomers (P1,
P2, and P3) of Ad11k or Ad21k bind to three molecules of
CD46(SCR1-2) [1, 2, 6, 7, 17, 19] (Figure 1(a)). According to
the topology of Figures 1(c) and 1(d), each CD46(SCR1-2)
molecule binds two protomers of Ad11k or Ad21k. However,
one protomer in each complex contacts a larger surface area
on CD46(SCR1-2) and is responsible for a larger number of
intermolecular interactions.
Both conformation and electrostatics are thought to drive
the interaction of the adenovirus ligands to their receptor.
The free structure of CD46(SCR1–4) shows a bend between
SCR1 and SCR2, but CD46(SCR1-2)-Ad11k and CD46(SCR1-
2)-Ad21k show a more linear orientation of these domains,
suggesting a conformational change upon virus binding [1,
2, 17]. Also, the loop regions of Ad11k and Ad21k change
conformation before binding to CD46(SCR1-2) [1, 2]. Both
viral proteins in either complex bind to CD46(SCR1-2)
through Coulombic interactions and hydrogen bonds [1, 6].
Previous studies have shown that critical salt bridges exist
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between Glu63 of CD46(SCR1-2) and specific Arg residues
on Ad11k or Ad21k [1, 6, 13–15, 17].
Alanine-scanning mutagenesis has often been used to
determine the individual contributions of different residues
to a protein of interest [20]. In CD46(SCR1-2)-Ad11k and
CD46(SCR1-2)-Ad21k, certain residues can play critical roles
in facilitating binding stability. In these residues, the role
of the side chain functional groups can be inferred from
alanine mutations. However, generating libraries of mutant
proteins experimentally can be tedious and time-consuming.
Recently, computational alanine scanning has allowed the
calculation of alanine mutation effects on the binding free
energy of a protein complex [21–25].The systematicmutation
of residues by computational analysis allows the prediction
of mutations that can dramatically affect protein binding
affinity. Although the methodology is limited by factors such
as conformational changes and nonadditive effects, it is an
efficient way to yield an energy map of mutational pertur-
bations that reveal important interactions in CD46(SCR1-
2)-Ad11k and CD46(SCR1-2)-Ad21k. This energy map can
serve as a predictive tool in the selection of CD46(SCR1-2)
or adenovirus protein mutants with desired binding affinity
in experimental mutagenesis studies.
In this paper, we compare the electrostatic interactions
of Ad11k and Ad21k with their CD46(SCR1-2) receptor to
delineate similarities and differences in their binding mecha-
nisms.Weuse computational tools to perturb the electrostatic
network of CD46(SCR1-2) and the two adenovirus proteins
in order to identify and quantify the role of specific charged
amino acids in association and binding. Since CD46(SCR1-
2), Ad11k, and Ad21k all have an overall negative charge,
long-range recognition of CD46(SCR1-2) with Ad11k/Ad21k
is not initially favored. However, if there are localized charged
patches on both proteins in a complex, these patches may
facilitate long-range recognition as well as specific binding
at the interface of the complex. We propose a generalized
electrostatic hypothesis that contributes to the formation of
the two complexes and suggest specific amino acids that
are contributing to binding. Our analysis contributes to a
molecular understanding of the mechanisms of adenovirus
infection as well as provides a foundation for the design of
molecular inhibitors against Ad11k or Ad21k binding.
2. Methods
2.1. Preparation of Molecular Structures. Three-dimensional
coordinates of the complexes CD46(SCR1-2)-Ad11k and
CD46(SCR1-2)-Ad21k were obtained from the Protein Data
Bank [26], with PDB IDs 3O8E [19] and 3L89 [2], respectively.
For CD46(SCR1-2)-Ad11k, chain A for Ad11k and chain B
for CD46(SCR1-2) were selected because they had the least
number of missing residues. The missing residues on chain
A, 113–128, were terminal residues and were sufficiently away
from the binding site to be of concern; therefore, they were
not reconstructed. A full heterohexameric CD46(SCR1-2)-
Ad11kmodel was generated by applying a rotation/translation
matrix transformation on chains A and B as specified in the
PDB file header, using an R (https://www.r-project.org/ [27])
script. The resulting assembly consisted of a total of three
CD46(SCR1-2)-Ad11k complexes, according to the topology
of Figure 1(c), and a complex containing two protomers
bound to a single CD46(SCR1-2) molecule was extracted for
our analysis. In this complex, CD46(SCR1-2) contained only
modules SCR1 and SCR2, which participate inAd11k binding,
whereas modules SCR3 and SCR4 were deleted.The program
Chimera [28] was used to prepare the final CD46(SCR1-2)-
Ad11k complex.
For CD46(SCR1-2)-Ad21k, the PDB file had the truncated
version of CD46(SCR1-2) with only modules SCR1 and SCR2
present. PDB chains B and C for Ad21k and chain N for
CD46(SCR1-2) were chosen for the analysis (Figure 1(d)).
Chains B and C were chosen because they had the least
missing residues compared to other complexes.The Chimera
[28] “model/refine loops” interface ofModeller [29] was used
to construct nonterminal missing residues for Ad21k. The
missing residues are not located near the complex interface
and therefore may not directly affect association.
The modified PDB files for both complexes were used
to generate PQR files, containing atomic coordinates, partial
charges, and atomic radii using PDB2PQR [30, 31] server
with the PARSE [32] force field selection. To determine the
ionization state of each ionizable amino acid, apparent p𝐾
𝑎
values were precalculated using PROPKA [33, 34] server.This
information was used in setting up the Poisson-Boltzmann
electrostatic calculations, described below.
2.2. Alanine Scanning Mutagenesis. The integrated Analysis
of Electrostatic Similarities of Proteins (AESOP) [25] compu-
tational framework [23, 24, 35] was used to generate alanine
scan mutants of the adenovirus protein, Ad11k or Ad21k,
and CD46(SCR1-2) for each of the two complexes. AESOP
operates in the R [27] environment using custom-made R
scripts to systematically mutate the side chains of charged
ionizable residues (Arg, Asp, His, Glu, and Lys) into alanine,
one at a time, thus generating a family of mutant proteins.
Alanine is typically chosen as a charge-removal perturbation
with the least local structural perturbation, in analogy to
experimental alanine scan studies. Chimera [28] was used to
rename the two adenovirus chains into one chain, enabling
the separation of the complex into two components for the
electrostatic calculations. For each member of the mutant
family, separate PQR files were prepared for the complex and
the two individual components of the complex.
2.3. Calculation of Electrostatic Potentials. The Adaptive
Poisson-Boltzmann Solver (APBS) [36] was used to calculate
spatial distributions of electrostatic potentials for the alanine
scan mutant family and parent protein, using the linearized
Poisson-Boltzmann equation [23, 24] and parameters from
the PQR files. The protein molecular surface was calcu-
lated using a probe sphere with radius 1.4 A˚ and the ion
accessibility surface was defined using a probe sphere with
radius 2.0 A˚. Grid dimensions and lengths were determined
within AESOP in order to achieve < 1.0 A˚ grid resolution. For
CD46(SCR1-2)-Ad11k, grid dimensions were 161 × 129 × 97
and grid lengths were 135 A˚×96 A˚×116 A˚. For CD46(SCR1-
2)-Ad21k, grid dimensions were 161 × 129 × 97 and grid
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lengths were 138 A˚ × 119 A˚ × 96 A˚. The dielectric coefficient
was set to 𝜀
𝑝
= 20 for the protein interior and 𝜀
𝑠
= 78.54
for the solvent, unless noted otherwise below. The use of
an internal dielectric coefficient of 𝜀
𝑝
= 20 is justified in
a study of the parameterization of the AESOP framework
using alanine scan experimental data on protein complexes
with available crystal structures [35] and is in agreement
with earlier Poisson-Boltzmann parameterization data [37]
and numerous studies thereafter. Electrostatic potential cal-
culations were performed with ionic strength corresponding
to 150mM of monovalent counterion concentrations, at a
temperature of 298.15 K, to model experimental conditions.
APBS electrostatic potentials were calculated for each of
the protein complexes and individual protein components,
and electrostatic maps were generated with Chimera [28].
Chimera and custom R scripts were also used for calculation
of distances in pairwise electrostatic interactions, such as
Coulombic and hydrogen bonding. A cutoff distance of 8 A˚
was used for Coulombic interactions, with those below 5 A˚
referred to as salt bridges, hereafter. Chimera was used to
calculate hydrogen bonds, according to standard geometric
criteria [38]. For each complex, the surface areas of individual
proteins and the complex were measured with Chimera,
after adding hydrogen atoms to the crystal structures. SASA
was then calculated by taking the difference between the
sum of individual protein surface areas and the complex
surface area. Van derWaals interactionswere calculated using
distance criteria with customR scripts, whichmade use of the
CD46(SCR1-2)-Ad11k and CD46(SCR1-2)-Ad21k PDB files.
2.4. Calculation of Electrostatic Free Energy of Binding. Six
calculations of electrostatic potentials and electrostatic free
energies were performed using APBS, as described in [23,
24, 35, 39], with each calculation corresponding to the
reactants and products of the thermodynamic cycle shown
in Supplementary Figure S1 of the Supplementary Material
available online at http://dx.doi.org/10.1155/2015/967465. In
preparation for the calculations, all structures of the mutant
complexes were centered on the coordinates of the parent
protein complex to eliminate grid artifacts and allow for accu-
rate comparison of electrostatic potentials and electrostatic
free energies of binding within each family of mutants. After
introduction of mutations using AESOP, as described above,
the components of each complex were separated to generate
the reactants of the thermodynamic cycle of Supplementary
Figure S1. The thermodynamic cycle contains a reference
binding state (top horizontal process) and a solution binding
state (bottom horizontal process). Electrostatic potentials for
the solution state were calculated with parameters described
above (and shown in Supplementary Figure S1), while those
of the reference state were calculated using the same dielectric
coefficient of 20 for both the protein interior and solvent, in
the absence of ionic strength.Therefore, the vertical processes
denote solvation. Electrostatic free energies of binding were
calculated for CD46(SCR1-2) and its corresponding aden-
ovirus protein to show mutant effects on thermodynamic
stability in each complex. The reported electrostatic free
energies of binding for the mutants are relative to the parent
protein (also called wild type, WT) and are given as
Δ𝐺
binding
= Δ𝐺
solution
mutant − Δ𝐺
solution
parent , (1)
where Δ𝐺solutionmutant and Δ𝐺
solution
parent correspond to
Δ𝐺
solution
= ΔΔ𝐺
solvation
+ Δ𝐺
Coulombic (2)
as previously described [23, 40] (see Supplementary Figure S1
for description of the electrostatic free energy components).
2.5. Electrostatic Clustering ofMutants. Electrostatic similari-
ties for the families of CD46(SCR1-2) and adenovirus protein
mutants were calculated using the electrostatic similarity
distance (ESD) equation [23, 24, 39]:
ESD = 1
𝑁
∑
𝑖,𝑗,𝑘
󵄨󵄨󵄨󵄨𝜙𝐵 (𝑖, 𝑗, 𝑘) − 𝜙𝐴 (𝑖, 𝑗, 𝑘)
󵄨󵄨󵄨󵄨
max (󵄨󵄨󵄨󵄨𝜙𝐴 (𝑖, 𝑗, 𝑘)
󵄨󵄨󵄨󵄨 ,
󵄨󵄨󵄨󵄨𝜙𝐵 (𝑖, 𝑗, 𝑘)
󵄨󵄨󵄨󵄨)
, (3)
where 𝜑
𝐴
and 𝜑
𝐵
are the electrostatic potentials of proteins
𝐴 and 𝐵, respectively, at grid point (𝑖, 𝑗, 𝑘), and 𝑁 is the
total number of grid points. An 𝑛 × 𝑛 pairwise comparison
of distance matrix was generated, where 𝑛 is the number of
mutants plus the parent protein. An ESD value of 0 represents
identical electrostatic potentials, with an increasing value
denoting increasing dissimilarity. Mutants were clustered in
dendrograms based on their ESD values, using a hierarchical
clustering with an average linkage algorithm, implemented
in R [23, 24, 39]. Clustering was performed for proteins
in each of the two complexes, CD46(SCR1-2)-Ad11k and
CD46(SCR1-2)-Ad21k.
3. Results
Our goal is to elucidate the role of charge in the inter-
action of CD46(SCR1-2) with Ad11k and Ad21k. Although
CD46(SCR1-2), Ad11k, and Ad21k have negative net charges
of −6, −8, and −6, respectively, they are able to form the
complexes CD46(SCR1-2)-Ad11k and CD46(SCR1-2)-Ad21k.
We used electrostatic potentials, electrostatic free energies of
binding, hierarchical clustering, and local physicochemical
analysis at the protein-protein interfaces to propose a mech-
anism of association.
The surface at the interface of CD46(SCR1-2) with
Ad11k/Ad21k is composed of localized regions of positive
and negative electrostatic potential projections (Figure 2),
which contribute to the makeup of the charged macrodipoles
of the proteins, and therefore to nonspecific, long-range
recognition step of association. These regions are organized
into distinct patches, reflecting the types of residues that
dominate the patches, and also contribute to the binding
step of association through specific short-range electrostatic
interactions. For example, positive patches contain an excess
of Arg and Lys residues, while negative patches contain an
excess of Asp and Glu residues. Visual inspection of Figure 2
reveals a positive center around Arg280(A) in Ad11k and
around Arg247(B)/Arg279(B) in Ad21k with a negative patch
Molecular Biology International 5
E196(A)
E285(A)
D284(A)
R279(A)
R280(A)
R266(E)
D300(E)
Ad11k
K119
E63
K29
R25
D27
180∘ CD46(SCR1-2)
(a)
K119
R69 E63
K32
K29
D27
R279(B) R247(B)
D179(C)
E299(C)
E302(C)
Ad21k
E148(B)
R195(B)
E208(B)
K212(B)
E292(B)
CD46(SCR1-2)180∘
(b)
Figure 2: Electrostatic maps of binding sites for CD46(SCR1-2)-Ad11k (a) and CD46(SCR1-2)-Ad21k (b). Both complexes use localized
positive and negative patches for complementary binding. Each panel is an open-book view of each complex, where the left image reflects
the right image around the vertical axis. The transparent outlines show the position of the partner protein in the complex. Acidic residues
reside in red spots (−3𝑘BT/e) while basic residues reside in blue spots (+3𝑘BT/e). Residues from Table 1 that contribute to distinguishable
electrostatic regions are labeled. Ad11k and Ad21k are composed of two different chains, as indicated by the letter in parentheses. Molecular
graphics were generated using Chimera [28].
on top of it. Complementary patches are in theCD46(SCR1-2)
contacts, with a negative center around Glu63 and a positive
patch above it.
Table 1 summarizes all Coulombic interactions at the
interface using an 8 A˚ cutoff distance. Although both com-
plexes distribute their charged residues at the interface
for complementary binding, their charge distributions are
distinct. The surface maps of Figure 3 show the location
of residues that are involved in any Coulombic interac-
tions. CD46(SCR1-2)-Ad11k has two medium-strong favor-
able Coulombic interactions at 5 A˚ or less (called salt bridges
herein) and five weaker Coulombic interactions in the
range of 5–8 A˚ (called weak Coulombic interactions herein),
whereas CD46(SCR1-2)-Ad21k has three salt bridges and
four weak Coulombic interactions (Table 1). Both complexes
have unfavorable Coulombic interactions, one strong and one
weak for Ad11k and one strong and four weak for Ad21k.
Overall, both complexes appear to have similar Coulombic
interactions contributing to the binding free energies of the
two complexes.
Based on the data of Table 1, a central residue for binding
is Glu63 of CD46(SCR1-2), located in the intermodular linker
of SCR1-SCR2, because it makes salt bridge contacts with
positively charged residues in Ad11k/Ad21k. Therefore Glu63
is a key residue for the stability of CD46(SCR1-2)-Ad11k and
CD46(SCR1-2)-Ad21k. Previous studies have also pointed out
that Glu63 is an important binding residue for Ad11k [2, 6, 13]
or Ad21k [2].
Table 2 shows intermolecular hydrogen bonds for all
residues in CD46(SCR1-2) and the adenovirus proteins.
CD46(SCR1-2)-Ad11k has 11 hydrogen bonds (involving 8
distinct residues in CD46(SCR1-2) and 7 distinct residues
in Ad11k), while CD46(SCR1-2)-Ad21k has 8 hydrogen
bonds (involving 8 distinct residues in both CD46(SCR1-
2) and Ad21k). Most of the additional hydrogen bonds
in CD46(SCR1-2)-Ad11k come from the interactions of the
Ad11k protomer 1 with CD46(SCR1-2). Overall, the larger
hydrogen bond count contributes to a more favorable
enthalpic component of the binding free energy for Ad11k.
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Table 1: Intermolecular Coulombic interactions.a
Interactions for CD46(SCR1-2)-Ad11k (chain A)
CD46(SCR1-2) Residue number Atom Ad11k Residue number Atom Distance (A˚)
Arg 25 CZ Glu 285 CD 5.0
Arg 25 CZ Asp 284 CG 6.3
Asp∗ 27 CG Glu 285 CD 4.9
Asp∗ 27 CG Asp 284 CG 6.6
Lys 29 NZ Glu 196 CD 7.4
Glu 63 CD Arg 280 CZ 4.0
Glu 63 CD Arg 279 CZ 7.7
Interactions for CD46(SCR1-2)-Ad11k (chain E)
CD46(SCR1-2) Residue number Atom Ad11k Residue number Atom Distance (A˚)
Glu 63 CD Arg 266 CZ 7.3
Lys 119 NZ Asp 300 CG 6.1
Interactions for CD46(SCR1-2)-Ad21k (chain B)
CD46(SCR1-2) Residue number Atom Ad21k Residue number Atom Distance (A˚)
Glu∗ 11 CD Glu 148 CD 7.7
Asp∗ 27 CG Glu 208 CD 7.8
Lys∗ 29 NZ Arg 195 CZ 7.7
Lys∗ 29 NZ Lys 212 NZ 7.8
Lys∗ 32 NZ Arg 195 CZ 4.3
Lys 32 NZ Glu 148 CD 7.1
Lys 32 NZ Glu 292 CD 7.9
Glu 63 CD Arg 247 CZ 4.5
Glu 63 CD Arg 279 CZ 4.0
Interactions for CD46(SCR1-2)-Ad21k (chain C)
CD46(SCR1-2) Residue number Atom Ad21k Residue number Atom Distance (A˚)
Arg 69 CZ Asp 179 CG 6.1
Lys 119 NZ Glu 299 CD 4.6
Lys 119 NZ Glu 302 CD 7.3
aPairs of residues in bold faced characters denote interactions within 5 A˚.
∗ denotes unfavorable interactions.
At the interface, CD46(SCR1-2)-Ad11k has a buried sol-
vent accessible surface area (SASA) of 1841 A˚2 while the
CD46(SCR1-2)-Ad21k has a buried SASA of 2286 A˚2, mean-
ing that CD46(SCR1-2)-Ad11k has ∼19.5% smaller area of
interaction than CD46(SCR1-2)-Ad21k. The larger buried
SASA of CD46(SCR1-2)-Ad21k also suggests a larger number
of water molecules excluded from the binding interface and
released in the bulk solvent, therefore contributing to more
favorable entropic effects in the binding free energy. At the
same time, this larger SASA implies a larger number of side
chains with constrained conformational freedom, contribut-
ing to compensatory, less favorable entropic effects. We also
calculated van der Waals interactions (atom-atom contacts
within 4 A˚) for each complex and found that CD46(SCR1-
2)-Ad11k has 131 (28 from nonpolar atom pairs) interactions,
whereas CD46(SCR1-2)-Ad21k has 184 interactions (79 from
nonpolar atom pairs), corresponding to 51 more nonpolar
contacts forAd21k compared toAd11k.This is not unexpected
given that CD46(SCR1-2)-Ad21k has higher buried SASA.
These van der Waals interactions correspond mainly to
hydrophobic contributions to binding. Overall, the larger
number of nonpolar interactions contributes to a more
favorable enthalpic component of the binding free energy for
Ad21k.
Our hydrogen bonding, salt bridge, and SASA data are
overall in agreement with data from the PDBePISA server
(http://www.ebi.ac.uk/pdbe/prot int/pistart.html) [41], with
the exception of some potentially very weak hydrogen bonds
suggested by PDBePISA, corresponding to donor-acceptor
distances> 3.5 A˚. It should be noted that our analysis includes
both favorable and unfavorable Coulombic interactions up to
8 A˚. The PDBePISA analysis showed very small but similar
gain in the solvation free energy upon formation of both
complexes (without including interfacial hydrogen bond and
salt bridge contributions).
Through a systematic alanine scan of charged residues,
we determined the contribution of each charged amino
acid to the electrostatic component of the binding free
energy in both complexes. We calculated electrostatic free
energies of binding for the two families of mutants and
parent proteins, as described in Section 2.4. Figure 4 shows
graphs of differences between electrostatic free energies of
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Figure 3: Coulombic interaction maps for CD46(SCR1-2)-Ad11k (a) and CD46(SCR1-2)-Ad21k (b). In accordance with Table 1, both
complexes have residues that participate in intermolecular Coulombic interactions at the interface. Residues that form only weak interactions
are highlighted in purple, while residues that form at least one medium interaction are highlighted in orange. No strong Coulombic
interactions are present. Each panel is an open-book view of each complex, where the left image reflects the right image around the vertical
axis.The transparent outlines show the position of the partner protein in the complex. Ad11k and Ad21k residues can come from two different
chains, as indicated by the letter in parentheses. Molecular graphics were generated using Chimera [28].
binding (1) for CD46(SCR1-2) from its complexes with the
Ad11k (Figure 4(a)) and Ad21k (Figure 4(b)), respectively.
Supplementary Figures S2 and S3 show similar graphs for
Ad11k and Ad21k. Positive Δ𝐺binding values indicate that the
complex is thermodynamically less stable than the parent
protein complex, whereas negative Δ𝐺binding values indicate
a more stable complex than the parent complex. Thus, a
positive Δ𝐺binding sign indicates a loss of binding, whereas
a negative Δ𝐺binding sign indicates a gain of binding upon
mutation. The free energy maps of Figures 5 and 6 show
the location of individual residues that have experienced
significant loss or gain of binding (See Supplementary Tables
1–3 for Δ𝐺binding values). In both complexes, the majority
of mutations resulted in a loss of binding. Mutated residues
that contribute to more than 2.5 kJ/mol in the free energy
differences are considered to be more influential for binding,
and they are marked in Figure 4 (the chosen 2.5 kJ/mol value
corresponds to the thermal energy at room temperature).
The data of Figure 4 quantify that Glu63 of CD46(SCR1-
2) has the strongest contribution to binding, followed by
Lys119 in both complexes, and also Arg25 in the case of Ad11k.
This is in agreement with the assessment of intermolecular
interactions discussed above on the basis of visualization and
charge-charge distances in Coulombic interactions (Figures
2 and 3). The electrostatic potential of the Glu63Ala mutant
appears to be unique, as it clusters on its own in the
electrostatic clustering dendrograms (Supplementary Figures
S4 and S5), and it shows the largest loss of binding effect in
the free energy plots (Figure 4 and Supplementary Table S1),
compared to other acidic mutants. It appears that Glu63 is
a key residue for the interaction of CD46(SCR1-2) with the
adenovirus proteins, perhaps because of its unique position in
the intermodule SCR1-SCR2 linker. In the case of the complex
of CD46(SCR1-2) with Ad11k, removal of the unfavorable
Asp27-Glu285(A) interaction, by replacing Asp27 with Ala,
resulted in the strongest predicted gain of binding (Figure 4).
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Table 2: Intermolecular hydrogen bonds.
Interactions for CD46(SCR1-2)-Ad11k (chain A)
CD46(SCR1-2) Residue number Atom Ad11k Residue number Atom Distance (A˚)
Tyr 28 O Asn 283 ND2 3.7
Cys 30 N Ile 282 O 3.0
Tyr 36 N Ala 281 O 2.9
Tyr 36 O Asn 245 ND2 3.3
Thr 42 N Asp 284 OD2 2.8
Thr 42 OG1 Asp 284 N 3.1
His 43 ND1 Asp 284 OD2 2.8
Ser 112 OG Glu 196 OE2 3.1
Interactions for CD46(SCR1-2)-Ad11k (chain E)
CD46(SCR1-2) Residue number Atom Ad11k Residue number Atom Distance (A˚)
Thr 64 O Arg 266 NH1 2.9
Thr 64 O Arg 266 NH2 3.5
Ala 114 O Arg 266 NH1 2.8
Interactions for CD46(SCR1-2)-Ad21k (chain B)
CD46(SCR1-2) Residue number Atom Ad21k Residue number Atom Distance (A˚)
Cys 30 N Ile 281 O 3.2
Tyr 36 N Thr 280 O 2.7
Thr 64 OG1 Thr 245 O 2.6
Ser 112 O Arg 247 NH1 3.3
Interactions for CD46(SCR1-2)-Ad21k (chain C)
CD46(SCR1-2) Residue number Atom Ad21k Residue number Atom Distance (A˚)
Arg 69 O Asn 304 ND2 3.5
Trp 116 N Tyr 263 O 3.2
Lys 119 NZ Ser 300 O 3.0
Pro 120 O Ser 303 OG 3.3
In general, the electrostatic free energy data (Figure 4) are in
agreement with the distance-based evaluation of Coulombic
interactions (Table 1). Similar arguments can be made for
the Δ𝐺binding of Ad11k and Ad21k, shown in Supplementary
Figures S2 and S3. However, the electrostatic free energy
data reveal less obvious weak binding contributions from
residues that are beyond the 8 A˚ distance that was used to
define the binding interface. For completion, electrostatic
clustering dendrograms for Ad11k and Ad21k are shown in
Supplementary Figures S6 and S7.
Although the presence of surface patches with like
charges produce unfavorable Coulombic interactions, this
effect can be compensated by the introduction of favor-
able intermolecular Coulombic interactions at the binding
interface and by solvation effects, depending on number,
magnitude, and location of intermolecular interactions. To
delineate the relative Coulombic and solvation contribu-
tions in each mutant and parent protein, we examined
the raw electrostatic free energies of association, Δ𝐺solution,
for each mutant and parent protein and their decomposi-
tion into Coulombic and solvation contributions, according
to the thermodynamic cycle of Supplementary Figure S1.
Supplementary Figures S8–S11 show the electrostatic free
energy decomposition for each of the four proteins in the
CD46(SCR1-2)-Ad11k and CD46(SCR1-2)-Ad21k complexes.
As expected Δ𝐺Coulombic and ΔΔ𝐺solvation show opposite
trends [35], and their combined magnitudes determine
if the much smaller magnitude Δ𝐺solution will be overall
favorable (negative) or unfavorable (positive). Based on the
values and sign of the calculated Δ𝐺solution, CD46(SCR1-
2)-Ad11k appears to be electrostatically more stable than
CD46(SCR1-2)-Ad21k; however, Δ𝐺solution (Coulombic and
solvation effects) may not be the dominant contribution
to the overall stability of the complexes, and one should
consider additional energetic contributions (hydrogen bonds
and nonpolar interactions), as well as entropic contributions.
4. Discussion
4.1. Complementary Surface Patches Stabilize Both Complexes.
The effects of mutations of residues at the complementary
charged surface patches discussed above are depicted in
the free energy graphs of Figure 4 and are summarized in
Supplementary Tables S1–S3. For example, in the case of the
CD46(SCR1-2) free energy graph, the Glu63 mutant has a
significantly higher (loss of binding) Δ𝐺binding (>6 kJ/mol)
than othermutants (Figure 4).The higherΔ𝐺binding for Glu63
comes from its primary contribution to the central nega-
tive patch of CD46(SCR1-2), which aligns with the central
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Figure 4: Electrostatic free energies of binding for CD46(SCR1-2) mutants in complex with Ad11k (a) and Ad21k (b). Charged residues in
CD46(SCR1-2) were systematically mutated into alanine, one at a time as described in the text, to generate a family of as many mutants as
ionizable residues in the protein. The type of residue, residue number, and chain letter (in parentheses) for each mutant are shown. Negative
and positiveΔ𝐺 values represent increased and decreased thermodynamic stability of mutant complexes relative toWT (parent), respectively.
Highlighted residues are involved in specific binding and are grouped based on the distance of their closest Coulombic interaction. All other
charged residues have weak or diminishing Coulombic interactions at more than 8 A˚ apart. The order of CD46(SCR1-2) mutants in (a) and
(b) corresponds to the order in the dendrograms of Figures S4 and S5, respectively.
positive patch of Ad11k and Ad21 upon complex forma-
tion (Figure 2). Specifically, Glu63 forms a salt bridge with
Arg280(A) in Ad11k and a bifurcated salt bridge with
Arg247(B) and Arg279(B) in Ad21k, as shown in Figure 7.
Therefore, removing Glu63 would significantly reduce patch
complementation and loss of pairwise interactions with the
aforementioned Arg residues in Ad11k/Ad21k, with the effect
beingmore prominent in Ad21k because of the bifurcated salt
bridge (Table 1, Figure 7).
Unlike the Arg residues of Ad11k/Ad21k, Glu63 does not
have nearby negative residues that can compensate for its
mutation, so its Δ𝐺binding is considerably higher than other
mutations. Thus, there are specific charged residues in the
center of Ad11k or Ad21k and CD46(SCR1-2) that destabilize
the complex when mutated. Since these residues exist in
oppositely charged surface patches, patch complementation
and specific pairwise interactions play a significant role in
stabilizing both complexes.
Similarly, in the case of the Ad11k free energy graph, the
Arg266(E)Ala, Arg279(A)Ala, and Arg280(A)Ala mutants
all have relatively higher positive Δ𝐺binding (>3 kJ/mol) than
that of the wild type (Supplementary Figure S2). The three
residues belong to the same Ad11k central positive patch,
which aligns with a central negative patch containing Glu63
on CD46(SCR1-2) (Figure 2). For the Ad21k free energy
graph, the Arg247(B)Ala and Arg279(B)Ala mutants also
show positiveΔ𝐺binding (Supplementary Figure S3) and reside
in a positive patch that aligns with Glu63 of CD46(SCR1-
2) (Figure 2). Because mutating any of these Arg residues
diminishes the corresponding patch size, the higherΔ𝐺binding
likely comes from a weakening of patch complementation.
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Figure 5:Maps of electrostatic free energy of binding for CD46(SCR1-2)-Ad11k at the binding site (a) and at the surface opposite to the binding
site (b). The maps show the effect of mutating individual charged residues on Δ𝐺binding for the complex. Loss of binding mutants is shown in
pink (low; Δ𝐺binding = 0.1 to 2.5 kJ/mol, where 2.5 kJ/mol is the thermal energy at room temperature) or red (high; Δ𝐺binding > 2.5 kJ/mol).
Gain of binding mutants is shown in cyan (low; Δ𝐺binding = −0.1 to −2.5 kJ/mol) or purple (high; Δ𝐺binding < −2.5 kJ/mol). Other mutants
with −0.1 < Δ𝐺binding < 0.1 kJ/mol are grayed out. See Supplementary Material for details. Mutants with high Δ𝐺binding are labeled. Each
panel is an open-book view of the complex, where the left image reflects the right image around the vertical axis. (a) and (b) are related by a
180∘-rotation about a vertical axis.The transparent outlines show the position of the partner protein in the complex. Molecular graphics were
generated using Chimera [28].
With the distribution of positive and negative charge
on both proteins, the patch charge roles can be reversed.
For Ad11k, the large negative patch near Asp300(E) comple-
ments with the protruded positive patch containing Lys119
on CD46(SCR1-2) (Figure 2). For Ad21k, Glu299(C) also
resides in a large negative patch that aligns with Lys119. The
Asp300(E)Ala mutant has a Δ𝐺binding of 1.46 kJ/mol and the
Glu299(C)Ala mutant has a Δ𝐺binding of 1.22 kJ/mol. These
mutations diminish the corresponding negative patch, which
would then be less amenable to align with positive patch of
Lys119. Granted, there are nearby negative residues that can
compensate for the loss of Asp300(E) or Glu299(C), but their
absence still results in a less stable complex.
For the Lys119Ala mutant of CD46(SCR1-2), the free
energy graph of CD46(SCR1-2) shows a more pronounced
Δ𝐺
binding of approximately 5 kJ/mol in both complexes
(Figure 4). Unlike Asp300(E) of Ad11k or Glu299(C) of
Ad21k, Lys119 is responsible for a much more confined
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Figure 6: Maps of electrostatic free energy of binding for CD46(SCR1-2)-Ad21k at the binding site (a) and at the surface opposite to the
binding site (b). Presentation and notation is as in Figure 5.
charged area. Hence, the mutation of Lys119 would strongly
diminish the corresponding positive patch on CD46(SCR1-
2). Without Lys119, the large opposing negative patch
containing Asp300(E) on Ad11k or Glu299(C) on Ad21k
would be heavily compromised in electrostatic alignment. In
other words, the high Δ𝐺binding values of Lys119 show how
effectively this mutation destabilizes both complexes. For
both CD46(SCR1-2)-Ad11k and CD46(SCR1-2)-Ad21k, free
energies are a strong indicator that complementary surface
patches provide electrostatic stability.
The role of additional complementarymutations involved
in stabilizing or destabilizing pairwise interactions, but not
located in the charged surface patches discussed above, can
be depicted by examining Figure 4, Supplementary Figures S2
and S3, and Supplementary Tables S1–S3. The specific inter-
molecular Coulombic and hydrogen bonding interactions
can be seen in Tables 1 and 2, respectively.
4.2. CD46(SCR1-2)-Ad11k Is Stabilized by a Larger Num-
ber of Hydrogen Bonds Compared to CD46(SCR1-2)-Ad21k.
Cupelli et al. [2] point out that both protein complexes
have similar association rate constants (𝑘
𝑎
) and likely form
complexes using similar recognition processes. As Figure 2
shows, this recognition occurs from patch complementa-
tion between CD46(SCR1-2) and the adenovirus proteins.
However, CD46(SCR1-2)-Ad21k has a much greater dissoci-
ation rate constant (𝑘
𝑑
), resulting in lower binding affinity
(higher dissociation constant, 𝐾
𝐷
= 𝑘
𝑑
/𝑘
𝑎
). According to
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Figure 7: Distances for salt bridge interactions of Glu63 in CD46(SCR1-2) with Arg residues in Ad11k (a) and Ad21k (b). It is noted that,
in Ad21k, Glu63 forms a bifurcated salt bridge with Arg247(B) and Arg279(B), whereas, in Ad11k, Glu63 forms a single salt bridge with
Arg280(A), using a cutoff distance of 5 A˚ for salt bridge formation. Molecular graphics were generated using Chimera [28].
Table 2, CD46(SCR1-2)-Ad11k has 43% more intermolecular
hydrogen bonds but 19.5% less SASA than CD46(SCR1-2)-
Ad21k. We speculate that the additional hydrogen bonds
play a dominant role in stabilizing the CD46(SCR1-2)-
Ad11k. Nonetheless, the larger binding area of Ad21k would
contribute to the stability of the interface because of addi-
tional nonpolar interactions. The 22-fold higher affinity of
Ad11k compared to Ad21k, expressed as ratio of 𝐾
𝐷
values,
corresponds to ∼8 kJ/mol binding free energy difference.
Considering that a typical hydrogen bond energy can be
up to 6 kJ/mol [42], the 11 hydrogen bonds of CD46(SCR1-
2)-Ad11k would contribute up to 66 kJ/mol to the binding
affinity, and the 8 hydrogen bonds of CD46(SCR1-2)-Ad21k
would contribute up to 48 kJ/mol.The difference of 18 kJ/mol
in hydrogen bonding is in favor of CD46(SCR1-2)-Ad11k
stabilization compared to CD46(SCR1-2)-Ad21k (note that
these contributions are estimates because we do not use
variable distance and angle criteria and are used simply
to denote which complex may be generally more favorable
based on counting hydrogen bonds). Based on qualitative
distance arguments, and although we have not taken into
account effects owed to position-dependent variable dielec-
tric coefficients, a coarse estimate of Coulombic interac-
tions suggests that Ad11k and Ad21k should have similar
electrostatic contributions to binding (vide supra). On the
other hand, the increased interfacial SASA of CD46(SCR1-
2)-Ad21k provides a 9.3 kJ/mol advantage for this complex
(using a nonpolar energy approximation as in MM-GBSA
calculations [20], with surface tension parameter equal to
0.0209 kJ/mol/A˚2). In combination, these estimates suggest
that CD46(SCR1-2)-Ad11k may be favored energetically over
CD46(SCR1-2)-Ad21k, by ∼9 kJ/mol. It should be noted that
these calculations provide a very approximate estimate of
intermolecular energies and neglect the fact that intermolec-
ular contacts may be dynamically forming and deforming.
Also, the calculations neglect the frequency of contacts given
that we use static crystallographic structures, as well as any
entropic effects upon binding and desolvation.
4.3. Association Model for CD46(SCR1-2)-Ad11k and
CD46(SCR1-2)-Ad21k. The hypothesis underlying our study
assumes a two-step electrostatics-based model of association
[23–25, 35, 40, 43] between CD46(SCR1-2) and the adeno-
virus proteins. According to this model, the first step, which
is the recognition step, involves nonspecific long-range elec-
trostatic interactions between the two proteins through the
interaction of protein macrodipoles. In the second step,
which is the binding step, the two proteins undergo confor-
mational and entropic changes to form specific pairwise
physicochemical interactions, including hydrophobic and
electrostatic (hydrogen bonding and Coulombic/solvation)
contacts, as well as solvent exclusion. Although both compo-
nents of the complexes, CD46(SCR1-2) and Ad11k/Ad21k,
have a negative net charge, the presence of complementary
surface patches of opposite charges (and electrostatic poten-
tials generated by these charges) is sufficient to accelerate
their encounter through long-range electrostatic interactions
and to lead to complex formation through short-range
pairwise interactions and entropic effects. The presence
of patches with like charges can be viewed as a stressed
Coulombic environment in the individual proteins, which
drives complex formation in order to at least partially
alleviate the stress by the formation of intermolecular
electrostatic contacts. Therefore, the two-step association
model, consisting of weak and nonspecific electrostatic
recognition (step 1) and strong and specific binding (step 2),
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is expected to be operative in the case of CD46(SCR1-2)-
Ad11k/Ad21k association. However, in the case of step 2,
compensatory enthalpic and entropic contributions may
make qualitative arguments less intuitive.
4.4. Gain or Loss of Binding Can Be Predicted by the Effect
of Computational Alanine Scans on Electrostatic Potentials.
Experimental alanine scans (and point mutations in general)
are perturbation methods that alter the physicochemical
composition of the local environment and are typically
used to elucidate the role of the mutated amino acids in
binding. Computational alanine scans (or other mutations)
and electrostatic calculations are useful to predict the role of
ionizable amino acids in binding for highly charged proteins.
Such data are faster to generate than experimental data and
can guide subsequent experimental studies. Figures 4–6,
Supplementary Figures S2 and S3, and Supplementary Tables
S1–S3 provide databases of computationally predicted loss of
binding and gain of binding mutations for CD46(SCR1-2),
Ad11k, and Ad21k.
We have compared our computational results with an
experimental alanine scan that examined the interaction of
CD46(SCR1-2) mutants with Ad11k [5]. This study suggests
that mutating Arg25, Lys110, and Lys119 on CD46(SCR1-2)
results in ∼20% drop in binding efficiency compared to wild
type CD46, which is in agreement with our study. However,
the experimental study does not present data for the most
significant mutation according to our computational data,
that of Glu63Ala. It is likely that Glu63Alawas excluded in the
experimental study because it is located in the linker between
the two SCR domains; however, our experience with other
SCR-containing viral inhibitors of the complement system
suggests that charged linker residues play an important role
in recognition of complement protein targets [43–46]. The
experimental data shows no change in binding efficiency for
the Asp27Ala mutant, even though our computational anal-
ysis predicts that the mutant should experience a noticeable
gain in binding. This may be either due to the experimental
design or due to a nonphysiological conformation of Asp27
in the crystal structure of CD46(SCR1-2)-Ad11k, but not in
CD46(SCR1-2)-Ad21k, we used in our calculations. To the
best of our knowledge, there are no mutagenesis data on
CD46(SCR1-2)-Ad21k in the literature. Thus, we hope that
our computational results can act as a guide for future muta-
genesis experiments in order to target more relevant residues
that impact binding on CD46(SCR1-2) and Ad11k/Ad21k.
5. Conclusions
Despite the fact that CD46(SCR1-2) and the adenovirus
proteins Ad11k/Ad21k have negative net charge, they are still
able to associate with stable complexes. This is because of
the presence of oppositely charged patches on the surfaces of
CD46(SCR1-2) andAd11k/Ad21k, which allow the adenovirus
proteins to recognize CD46(SCR1-2) and promote binding,
in addition to nonelectrostatic effects and entropic contribu-
tions. Such patches originate from the clustering of specific
charged groups on the protein surfaces. At the interface,
residues that contribute to binding participate in important
pairwise intermolecular interactions (hydrophobic and elec-
trostatic). Our electrostatic free energy graphs show that
mutations of ionizable residues at the complex interface cause
a more distinguishable change in the electrostatic energy of
binding for the complex. A critical residue for the formation
of CD46(SCR1-2)-Ad11k/Ad21k is Glu63 of CD46(SCR1-2),
which is involved in stabilizing Coulombic interactions in
both complexes.
Overall, this study has shown that electrostatics con-
tributes to the formation of CD46(SCR1-2)-Ad11k and
CD46(SCR1-2)-Ad21k. We propose specific mutations that
are predicted to be stabilizing or destabilizing of the com-
plexes. Upon experimental verification, this type of analysis
may be useful in designing CD46(SCR1-2)-like molecules
or CD46(SCR1-2)-derived peptide fragments that may be
potential Ad11k/Ad21k viral inhibitors. Alternatively, this type
of analysis may be useful in designing Ad11k/Ad21k-like
proteins or Ad11k/Ad21k-derived peptide fragments to serve
as inhibitors of CD46(SCR1-2) and complement activation,
which would be useful in cases of autoimmune diseases.
Finally, site-specific mutations could be used for developing
adenoviruses into better gene delivery vehicles, and combi-
natorial mutagenesis may lead to tailored protein variants, as
previously shown [43–46].
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